191 related articles for article (PubMed ID: 27846316)
1. The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Black RJ; Hill CL; Lester S; Dixon WG
PLoS One; 2016; 11(11):e0166468. PubMed ID: 27846316
[TBL] [Abstract][Full Text] [Related]
2. The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses.
Dixon WG; Suissa S; Hudson M
Arthritis Res Ther; 2011 Aug; 13(4):R139. PubMed ID: 21884589
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Risk of Glucocorticoid-Associated Adverse Effects in Patients With Rheumatoid Arthritis.
Wilson JC; Sarsour K; Gale S; Pethö-Schramm A; Jick SS; Meier CR
Arthritis Care Res (Hoboken); 2019 Apr; 71(4):498-511. PubMed ID: 29856128
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study.
Yamada Y; Tada M; Mandai K; Hidaka N; Inui K; Nakamura H
Clin Rheumatol; 2020 Jun; 39(6):1757-1764. PubMed ID: 31938882
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Bergstra SA; Sepriano A; Kerschbaumer A; van der Heijde D; Caporali R; Edwards CJ; Verschueren P; de Souza S; Pope JE; Takeuchi T; Hyrich KL; Winthrop KL; Aletaha D; Stamm TA; Schoones JW; Smolen JS; Landewé RBM
Ann Rheum Dis; 2023 Jan; 82(1):81-94. PubMed ID: 36410794
[TBL] [Abstract][Full Text] [Related]
6. What do we know about the safety of corticosteroids in rheumatoid arthritis?
Ethgen O; de Lemos Esteves F; Bruyere O; Reginster JY
Curr Med Res Opin; 2013 Sep; 29(9):1147-60. PubMed ID: 23790244
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity.
Carli L; Tani C; Querci F; Della Rossa A; Vagnani S; Baldini C; Talarico R; d'Ascanio A; Neri R; Tavoni AG; Bombardieri S; Mosca M
Clin Rheumatol; 2013 Jul; 32(7):1071-3. PubMed ID: 23456414
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid-trials in rheumatoid arthritis mostly study representative real-world patients: A systematic review and meta-analysis.
Palmowski A; Nielsen SM; Buttgereit T; Palmowski Y; Boers M; Christensen R; Buttgereit F
Semin Arthritis Rheum; 2020 Dec; 50(6):1400-1405. PubMed ID: 32222381
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of systemic glucocorticosteroids for pain in rheumatoid arthritis: a systematic literature review and meta-analysis.
McWilliams DF; Thankaraj D; Jones-Diette J; Morgan R; Ifesemen OS; Shenker NG; Walsh DA
Rheumatology (Oxford); 2021 Dec; 61(1):76-89. PubMed ID: 34213524
[TBL] [Abstract][Full Text] [Related]
10. Quantifying cutaneous adverse effects of systemic glucocorticoids in patients with rheumatoid arthritis: a cross-sectional cohort study.
Amann J; Wessels AM; Breitenfeldt F; Huscher D; Bijlsma JWJ; Jacobs JWG; Buttgereit F
Clin Exp Rheumatol; 2017; 35(3):471-476. PubMed ID: 28094753
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy associated with long-term low-dose glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis.
Palmowski A; Nielsen SM; Boyadzhieva Z; Schneider A; Pankow A; Hartman L; Da Silva JAP; Kirwan J; Wassenberg S; Dejaco C; Christensen R; Boers M; Buttgereit F
Rheumatology (Oxford); 2023 Aug; 62(8):2652-2660. PubMed ID: 36810945
[TBL] [Abstract][Full Text] [Related]
12. Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis.
Schenfeld J; Iles J; Trivedi M; Accortt NA
Rheumatol Int; 2017 Jul; 37(7):1075-1082. PubMed ID: 28255642
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry.
Black RJ; Lester S; Buchbinder R; Barrett C; Lassere M; March L; Whittle S; Hill CL
Arthritis Res Ther; 2017 Nov; 19(1):253. PubMed ID: 29141677
[TBL] [Abstract][Full Text] [Related]
14. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.
Gorter SL; Bijlsma JW; Cutolo M; Gomez-Reino J; Kouloumas M; Smolen JS; Landewé R
Ann Rheum Dis; 2010 Jun; 69(6):1010-4. PubMed ID: 20448288
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids Are Associated with an Increased Risk for Vertebral Fracture in Patients with Rheumatoid Arthritis.
Kim D; Cho SK; Park B; Jang EJ; Bae SC; Sung YK
J Rheumatol; 2018 May; 45(5):612-620. PubMed ID: 29545455
[TBL] [Abstract][Full Text] [Related]
16. Controversies in rheumatoid arthritis glucocorticoid therapy.
Ruyssen-Witrand A; Constantin A
Joint Bone Spine; 2018 Jul; 85(4):417-422. PubMed ID: 29246530
[TBL] [Abstract][Full Text] [Related]
17. Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy.
Safy-Khan M; Jacobs JWG; de Hair MJH; Welsing PMJ; Edwardes MD; Teitsma XM; Luder Y; Devenport J; van Laar JM; Pethoe-Schramm A; Bijlsma JWJ
Ann Rheum Dis; 2020 Apr; 79(4):460-463. PubMed ID: 32033935
[TBL] [Abstract][Full Text] [Related]
18. Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids.
Hoes JN; van der Goes MC; van Raalte DH; van der Zijl NJ; den Uyl D; Lems WF; Lafeber FP; Jacobs JW; Welsing PM; Diamant M; Bijlsma JW
Ann Rheum Dis; 2011 Nov; 70(11):1887-94. PubMed ID: 21908880
[TBL] [Abstract][Full Text] [Related]
19. Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis.
Ravindran V; Rachapalli S; Choy EH
Rheumatology (Oxford); 2009 Jul; 48(7):807-11. PubMed ID: 19447767
[TBL] [Abstract][Full Text] [Related]
20. Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis.
Wang Y; Zhao R; Gu Z; Dong C; Guo G; Li L
Osteoporos Int; 2020 Aug; 31(8):1401-1409. PubMed ID: 32291467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
